Document is current
Any future updates will be listed below
-
Authors
Ponzio, Michela https://orcid.org/0000-0001-5245-0474
Santoni, Laura
Molina, Michela
Tavazzi, Eleonora
Bergamaschi, Roberto
-
Funding
Funding for this research was provided by:
Biogen
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 11 November 2024
Accepted: 15 November 2024
First Online: 12 December 2024
Declarations
:
: Ponzio M. has no conflicts of interest to declare; Santoni L. is an employee of and may hold stock in Biogen; Tavazzi E. received honoraria for speaking from Biogen Idec, Bristol-Meyers-Squibb; Molina M. is an employee of and may hold stock in Biogen; Bergamaschi R. received honoraria for speaking from Biogen, Merck Serono, Roche, Novartis, Celgene, Janssen, Sanofi Genzyme; research grants from Biogen, Merck Serono, Roche, Novartis, Sanofi Genzyme; congress and travel/accommodation expenses funded by Biogen, Merck Serono, Roche, Novartis, Sanofi Genzyme.
: The study protocol was approved by the Ethical Committee of the San Matteo Hospital in Pavia (PR 20180042426; 06/06/2018) and was conducted in accordance with the rules of the Declaration of Helsinki and all applicable local law requirements and regulations concerning the privacy and security of personal information, including the General Data Protection Regulation (GDPR) (EU) 2016/679. An informed consent form was obtained from all patients enrolled in the study.
